Summary
Detailed pharmacology: GLP-1 receptor binding in CNS, pancreas, GI tract. Glucose-dependent insulinotropic effects. Glucagon suppression. Delayed gastric emptying. Central appetite regulation.
Source hierarchy
- Peer-reviewed publications in NEJM, Lancet, JAMA, Diabetes Care
- FDA prescribing information and label updates
- Clinicaltrials.gov registered trial protocols
- USP <797>, <71>, <85> pharmacy quality standards
Related clinical pages
Note for patients: Clinical trial data on this site is summarized for general education. Specific dosing decisions, contraindication assessments, and treatment plans must be made with a licensed healthcare provider who has reviewed your full medical history.
